Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants

Pharmacology

Volumn 71, Issue 3, 2004, Pages 113-119

  Vento, G ^a,b   Matassa, P G ^a   Zecca, E ^a   Tortorolo, L ^a   Martelli, M ^a   De Carolis, M P ^a   Maggio, L ^a   Zini, G ^a   D'Onofrio, G ^a   Valentini, S ^a   Romagnoli, C ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Dexamethasone; Pulmonary mechanics; Tracheobronchial aspirate fluid cytology

Indexed keywords

DEXAMETHASONE; OXYGEN; STEROID;

ARTICLE; ASPIRATION; BIRTH WEIGHT; CELL COUNT; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DRUG EFFECT; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN CELL; LUNG COMPLIANCE; LUNG MECHANICS; MALE; NEUTROPHIL; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RISK; STATISTICAL SIGNIFICANCE; TRACHEOBRONCHIAL TREE; VENTILATOR;

AGE FACTORS; ANTI-INFLAMMATORY AGENTS; BODY FLUIDS; BRONCHI; CHRONIC DISEASE; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; LUNG DISEASES; MALE; RESPIRATORY MECHANICS; TIME FACTORS; TRACHEA;

EID: 2642543854     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077444     Document Type: Article

References (33)

1. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK, Gluck L: Elastase and α1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 1983;72:656-662.
2. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD: Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984;130:817-821.
3. Vento G, Romagnoli C, Zecca E, Matassa PG, Tortorolo L, De Carolis MP, d'Onofrio G, Zini G, Tommasi M, Fresu R, Zuppi C: Increased levels of soluble intercellular adhesion molecule-1, neutrophils and elastase in the lung of preterm infants with bronchopulmonary dysplasia. Prenat Neonat Med 1997;2:348-355.
4. Fox RB, Hoidal JR, Brown DM, Repine JE: Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes. Am Rev Respir Dis 1981;123:521-523.
5. Tortorolo L, Vento G, Matassa PG, Zecca E, Romagnoli C: Early changes of pulmonary mechanics to predict the severity of bronchopulmonary displasia in ventilated preterm infants. J Matern Fetal Neonatal Med 2002;12:332-337.
6. Avery GB, Fletcher AB, Kaplan M, Brudno DS: Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;75:106-111.
7. Davidson D, Drafta D, Wilkens BA: Elevated urinary leukotriene E4 in chronic lung disease of extreme prematurity. Am J Respir Crit Care Med 1995;151:841-850.
8. Wang JY, Yeh TF, Lin YJ, Chen WY, Lin CH: Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation. Pediatric Pulmonol 1997;23:193-197.
9. Durand M, Sardesai S, McEvoy C: Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: A randomised, controlled trial. Pediatrics 1995;95:584-590.
10. Vento G, Matassa PG, Ameglio F, Capoluongo E, Tortorolo L, Romagnoli C: Effects of early dexamethasone therapy on pulmonary fibrogenic mediators and respiratory mechanics in preterm infants. Eur Cytokine Netw 2002;13:207-214.
11. Yoder MC, Chua R, Tepper R: Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis 1991;143:1044-1048.
12. Halliday HL, Ehrenkranz RA, Doyle LW: Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. (Cochrane Review). Cochrane Database Syst Rev 2002;1:CD001146.
13. Romagnoli C, Zecca E, Tortorolo L, Vento G, Tortorolo G: A scoring system to predict the evolution of respiratory distress syndrome into chronic lung disease in preterm infants. Intensive Care Med 1998;24:476-480.
14. Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, Krause-Steinrauf H, Verter J, Korones SB, Lemons JA, Fanaroff AA, Stevenson DK: A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med 1998;338:1112-1118.
15. Romagnoli C, Zecca E, Vento G, Maggio L, Papacci P, Tortorolo G: Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. Pharmacology 1999;59:266-274.
16. Shinwell ES, Karplus M, Zmora E, Reich D, Rothschild A, Blazer S, Bader D, Yurman S, Dolfin T, Kuint J, Milbauer B, Kohelet D, Goldberg M, Arnon Y, Davidson S, Sirota L, Amitai M, Zaretsky A, Barak M, Gottfried S: Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child Fetal Neonat Edit 1996;74:F33-F37.
17. Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH: Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: A multicenter clinical trial. Pediatrics 1997;100:715-716.
18. Zecca E, Romagnoli C, Vento G: Early dexamethasone therapy and very low birth weight infants. Pediatrics 1996;98:799-800.
19. American Academy of Pediatrics (Committee on Fetus and Newborn) and Canadian Paediatric Society (Fetus and Newborn Committee): Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002;109:330-338.
20. Barrington KJ: The adverse neuro-developmental effects of postnatal steroids in the preterm infant: A systematic review of RCTs. BMC Pediatrics 2001;1:1 Article available from URL: http://www.biomedcentral.com/1471-2431/1/1.
21. Murphy BP, Inder TE, Huppi PS, Warfield S, Zientara GP, Kikinis R, Jolesz FA, Volpe JJ: Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001;107:217-221.
22. Durand M, Mendoza ME, Tantivit P, Kugelman A, McEvoy C: A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: Dynamic pulmonary mechanics, oxygenation, and ventilation. Pediatrics 2002;109:262-268.
23. Romagnoli C, Zecca E, Vento G, De Carolis MP, Papacci P, Tortorolo G: Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants. Intens Care Med 1999;25:717-721.
24. Vento G, Mele MC, Mordente A, Romagnoli C, Matassa PG, Zecca E, Zappacosta B, Persichilli S: High total antioxidant activity and uric acid in tracheobronchial aspirate fluid of preterm infants during oxidative stress: An adaptive response to hyperoxia? Acta Paediatr 2000;89:336-342.
25. Bhutani V, Abbasi S: Relative likelihood of bronchopulmonary dysplasia based on pulmonary mechanics measured in preterm neonates during the first week of life. J Pediatr 1992;120:605-613.
26. Gonzalez A, Tortorolo L, Gerhardt T, Rojas M, Everett R, Bancalari E: Intrasubject variability of repeated pulmonary function measurements in preterm ventilated infants. Pediatr Pulmonol 1996;21:35-41.
27. LeSouef PN, Lopes JM, England SJ, Bryan MH, Bryan AC: Influence of chest wall distortion on esophageal pressure. J Appl Physiol 1983;55:353-357.
28. Hummler H, Gerhardt T, Gonzalez A, Claure N, Everett R, Bancalari E: Increased incidence of sighs (augmented inspiratory efforts) during synchronized intermittent mandatory ventilation (SIMV) in preterm neonates. Pediatr Pulmonol 1997;24:195-203.
29. Lui K, Lloyd J, Ang E, Rynn M, Gupta JM: Early changes in respiratory compliance and resistance during the development of bronchopulmonary dysplasia in the era of surfactant therapy. Pediatr Pulmonol 2000;30:282-290.
30. Schleimer RP: Effects of glucocorticoid on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 1990;141:559-569.
31. Zentay Z, Sharaf M, Qadir M, Drafta D, Davidson D: Mechanism for dexamethasone inhibition of neutrophil migration upon exposure to lipopolysaccharide in vitro: Role of neutrophil interleukin-8 release. Pediatr Res 1999;46:406-410.
32. Sanders RJ, Cox C, Phelps D, Sinkin RA: Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with RDS. Pediatr Res 1994;36:122-128.
33. Yeh TF, Torre JA, Rastogi A, Anybuno MA, Pildes RS: Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind, controlled study. J Pediatr 1990;117:273-282.